GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 424 filers reported holding GLOBUS MED INC in Q3 2023. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $558,339,175 | +24.8% | 11,245,502 | +49.7% | 0.01% | +27.3% |
| Q2 2023 | $447,296,811 | +4.7% | 7,512,543 | -0.4% | 0.01% | 0.0% |
| Q1 2023 | $427,334,640 | -21.5% | 7,544,750 | +2.9% | 0.01% | -26.7% |
| Q4 2022 | $544,555,958 | +27.1% | 7,332,112 | +1.9% | 0.02% | +15.4% |
| Q3 2022 | $428,470,000 | +2.3% | 7,192,699 | -3.6% | 0.01% | +8.3% |
| Q2 2022 | $418,755,000 | -23.4% | 7,459,128 | +0.7% | 0.01% | -7.7% |
| Q1 2022 | $546,379,000 | +0.8% | 7,405,509 | -1.4% | 0.01% | +8.3% |
| Q4 2021 | $542,215,000 | -3.2% | 7,509,907 | +2.7% | 0.01% | -14.3% |
| Q3 2021 | $560,360,000 | -0.4% | 7,313,502 | +0.8% | 0.01% | 0.0% |
| Q2 2021 | $562,378,000 | +28.5% | 7,253,678 | +2.2% | 0.01% | +16.7% |
| Q1 2021 | $437,722,000 | -2.3% | 7,097,808 | +3.4% | 0.01% | -7.7% |
| Q4 2020 | $447,817,000 | +35.5% | 6,866,253 | +2.9% | 0.01% | +18.2% |
| Q3 2020 | $330,501,000 | -0.9% | 6,674,099 | -4.6% | 0.01% | -8.3% |
| Q2 2020 | $333,608,000 | +5.0% | 6,992,414 | -6.4% | 0.01% | -14.3% |
| Q1 2020 | $317,635,000 | -26.0% | 7,468,492 | +2.5% | 0.01% | -6.7% |
| Q4 2019 | $429,131,000 | +15.8% | 7,288,227 | +0.6% | 0.02% | +7.1% |
| Q3 2019 | $370,501,000 | +22.0% | 7,247,682 | +0.9% | 0.01% | +27.3% |
| Q2 2019 | $303,760,000 | -14.0% | 7,181,055 | +0.4% | 0.01% | -21.4% |
| Q1 2019 | $353,278,000 | +16.2% | 7,149,913 | +1.8% | 0.01% | 0.0% |
| Q4 2018 | $304,114,000 | -20.5% | 7,026,674 | +4.3% | 0.01% | -6.7% |
| Q3 2018 | $382,306,000 | +16.3% | 6,735,494 | +3.4% | 0.02% | +7.1% |
| Q2 2018 | $328,783,000 | +9.3% | 6,515,714 | +7.9% | 0.01% | +7.7% |
| Q1 2018 | $300,720,000 | +23.1% | 6,036,130 | +1.6% | 0.01% | +18.2% |
| Q4 2017 | $244,246,000 | +40.3% | 5,942,727 | +1.5% | 0.01% | +37.5% |
| Q3 2017 | $174,089,000 | -8.1% | 5,857,670 | +2.5% | 0.01% | -11.1% |
| Q2 2017 | $189,355,000 | +13.4% | 5,712,043 | +1.4% | 0.01% | 0.0% |
| Q1 2017 | $166,929,000 | +24.7% | 5,635,698 | +4.5% | 0.01% | +28.6% |
| Q4 2016 | $133,861,000 | +15.5% | 5,395,441 | +5.1% | 0.01% | 0.0% |
| Q3 2016 | $115,904,000 | -2.6% | 5,135,335 | +2.9% | 0.01% | 0.0% |
| Q2 2016 | $118,971,000 | +3.0% | 4,992,506 | +2.6% | 0.01% | 0.0% |
| Q1 2016 | $115,537,000 | -12.7% | 4,864,768 | +2.2% | 0.01% | -22.2% |
| Q4 2015 | $132,402,000 | -71.5% | 4,759,250 | -73.2% | 0.01% | -47.1% |
| Q3 2015 | $465,271,000 | +300.1% | 17,765,706 | +292.2% | 0.02% | +112.5% |
| Q2 2015 | $116,292,000 | +6.0% | 4,530,299 | +4.2% | 0.01% | +14.3% |
| Q1 2015 | $109,732,000 | +7.6% | 4,347,545 | +1.3% | 0.01% | 0.0% |
| Q4 2014 | $102,017,000 | +23.1% | 4,291,871 | +1.9% | 0.01% | +16.7% |
| Q3 2014 | $82,870,000 | -11.8% | 4,213,013 | +7.3% | 0.01% | -14.3% |
| Q2 2014 | $93,936,000 | -4.4% | 3,927,043 | +6.3% | 0.01% | -12.5% |
| Q1 2014 | $98,230,000 | +39.1% | 3,694,235 | +5.6% | 0.01% | +33.3% |
| Q4 2013 | $70,612,000 | +28.0% | 3,499,086 | +10.8% | 0.01% | +20.0% |
| Q3 2013 | $55,162,000 | +27.2% | 3,159,345 | +22.9% | 0.01% | 0.0% |
| Q2 2013 | $43,356,000 | – | 2,571,518 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 589,100 | $45,137,000 | 24.71% |
| Sterling Investment Advisors, Ltd. | 188,123 | $14,414,000 | 4.29% |
| Godshalk Welsh Capital Management, Inc. | 73,748 | $5,651,000 | 3.52% |
| Pembroke Management, LTD | 601,447 | $46,083,000 | 3.47% |
| Integral Health Asset Management, LLC | 150,000 | $11,493,000 | 3.30% |
| XXEC, Inc. | 51,925 | $3,978,000 | 3.03% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 615,000 | $47,122,000 | 2.42% |
| Van Berkom & Associates Inc. | 946,997 | $72,559,000 | 2.20% |
| RTW INVESTMENTS, LP | 1,670,811 | $128,018,000 | 1.93% |
| Sivik Global Healthcare LLC | 95,000 | $7,279,000 | 1.74% |